Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04101344 · ClinicalTrials.gov registry record · NA
Fiber Blends and Gut Microbiota (FB)
A NA study of Gut Microbiome, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT04101344: Completed NA study of Gut Microbiome, sponsored by Washington University School of Medicine.
NCT04101344 is a NA study of Gut Microbiome that has completed, run by Washington University School of Medicine. The registered enrollment target is 14 participants, below the 267-participant average among 22 other Gut Microbiome trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04101344, a NA study of Gut Microbiome, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine whether consuming snacks containing different blends of dietary fibers alters the type and number of bacteria found in your gut and improves markers of overall health.
Primary Outcome
Stool samples will be analyzed to determine changes in type and number of gut microbiota.
Conditions Studied
Interventions
- OTHER Two fiber-blend snack and four fiber-blend snack
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-08-26 |
| Est. Completion | 2020-06-01 |
| Phase | NA |
What the finished NCT04101344 record still lists
NCT04101344 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 267-participant average among 22 other Gut Microbiome trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Gut Microbiome appearing as the primary indexed condition, and to 1 intervention - of which Two fiber-blend snack and four fiber-blend snack is the first listed.
NCT04101344 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04101344 about?
NCT04101344 is a clinical study titled "Fiber Blends and Gut Microbiota (FB)". The purpose of this research study is to determine whether consuming snacks containing different blends of dietary fibers alters the type and number of bacteria found in your gut and improves markers of overall health.
What is the current status of trial NCT04101344?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2019-08-26. Estimated completion is 2020-06-01.
What conditions does trial NCT04101344 study?
This clinical trial studies the following conditions: Gut Microbiome.
What interventions are being tested in trial NCT04101344?
The interventions under investigation include: Two fiber-blend snack and four fiber-blend snack (OTHER).
Who is sponsoring clinical trial NCT04101344?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04101344 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gut Microbiome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04101344's enrollment target sits among peer trials
14 23rd of 22 the lowest of 22 other Gut Microbiome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gut Microbiome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Flourish: Exploring the Early Infant Gut Microbiome
RECRUITING · NA
-
The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study
RECRUITING · NA
-
Enhanced Nutritional Optimization in LVAD Trial
RECRUITING · NA
-
Feasibility and Potential Efficacy of Herbs and Spices for Improving Dietary Quality in College Students: A Pilot Study
RECRUITING · NA
-
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
RECRUITING · NA
-
The Effect Cranberry-Based Products on the Female Microbiome
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy